Diaphragm disease (DD) is a rare gastrointestinal condition considered characteristic of injury due to prolonged intake of nonsteroidal anti-inflammatory drugs (NSAIDs). 1 The disease is characterized by circumferential lesions of short length (<5 mm), located most commonly in the small intestine, causing multiple stenosis of the lumen. The importance of NSAID-related enteropathy has been emphasized recently, 2 but the histologic features of DD of the small intestine have been reported in only a limited number of cases. [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] The initial thorough description of DD by Lang et al 15 was followed by several others [16] [17] [18] [19] that have revealed few additional findings. These additional findings have included villous atrophy, 16 association or overlap with socalled neuromuscular and vascular hamartoma (NMVH), 17 rare association with pseudoneoplastic lesions such as inflammatory fibroid polyp (IFP), 18 and, recently, an entity called NSAID-associated submucosal fibrous nodules of the small intestine. 19 Cases in which NSAID intake could not be proven have also been published. 20 The need to better recognize the histologic features of DD has been increased by the appearance of novel clinical means of imaging and recognition of cases in the small intestine (eg, video capsule endoscopy and double-balloon endoscopy). The study has one aim: to describe the spectrum of histopathologic features of DD to provide knowledge useful to the diagnosis of this entity.
Materials and Methods
The Mayo Clinic Arizona Internal Review Board approved the study. Ten cases of patients who underwent resection of a portion of small intestine because of DD Upon completion of this activity you will be able to:
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were identified from the surgical pathology files 21 rather than pyloric gland.
The following gross features were also recorded: (1) diaphragms (number and location) defined as an intraluminal, circumferential, and protruding ridge of tissue with luminal stenosis; (2) length of intestine removed; (3) site of intestine involved by the diaphragms as described by the surgeon; (4) presence of circumferential ulceration; (5) ring-like depression on the external surface of the intestine; and (6) adipose tissue wrapping.
H&E-stained slides were used. Immunohistochemical stains for fascin (clone 55K-2, DAKO, Carpinteria, CA), CD34 (clone QbEnd-10, DAKO), smooth muscle actin (SMA; clone 1A4, DAKO), and CD68 (clone kp-1, DAKO) were used for the diagnosis of IFP and were performed according to the standard protocol for an automated immunostainer (DAKO Autostainer Universal, DAKO), following the manufacturer's directions. The dilutions used were as follows: CD34, 1:400; CD68, 1:300; fascin, 1:150; and SMA, 1:100. Positive and negative (omitting primary antibody) control samples were used for each antibody.
Results

Clinical Findings
Of the 10 cases identified, 7 patients were women and 3 were men. The median patient age was 69 years (range, 50-79 years; SD, 9.21 years). The clinical findings are summarized in zTable 2z. Five patients had been taking NSAIDs for more than 1 year at the time of resection; the remaining 5 patients had taken NSAIDs, not otherwise specified, at high and unspecified doses for more than 1 year in the past. No patient had a history of radiation enteritis, celiac disease, or potassium chloride intake. Nine patients were receiving pain control medications that included opioid analgesics. The impression of the surgeons was that they were dealing with an unclear cause of obstruction or with DD, while Crohn disease was not considered likely. Crohn disease had not developed in any patient at follow-up. HPF, high-power field; LPF, low-power field.
Pathologic Findings
The gross features zImage 1z were collected in all cases. The results are summarized in zTable 3z. The diaphragms varied in height from a tall, broad, ulcerated plica circularis (Image 1D), to an ulcerated hump, to a flat, nonspecific ulcer. The terminal 30 cm of ileum were not involved. Every case showed circumferential ulcerations at the tip of the diaphragms, as well as stenosis of the lumen and short ring-like puckering of the serosa in the same areas (Image 1A). Fat wrapping was not present.
The number of slides examined for each case ranged from 5 to 31 (median, 8 slides). The histopathologic findings are summarized in zTable 4z.
The diaphragms differed from intestine because of sclerosed eosinophilic connective tissue in the submucosa intermixed with smooth muscle, ganglion cells, nerve fibers, and vessels. The smooth muscle component was represented by a simple irregular thickening of the muscularis mucosae or, more commonly, by muscle bundle chaotically arranged. Round to oval, better circumscribed submucosal masses with smooth muscle bundles converging toward the overlying ulceration were also seen zImage 2z. The latter were invariably placed at the apex of the diaphragm. Submucosal NMVH-like changes were in continuity with the adjacent splayed and thickened muscularis mucosae. Fibrosis of the lamina propria was typically present between crypts and muscularis mucosae, often tapering in thickness toward the base of the diaphragms. In 1 patient, the presence of loose stroma between crypts and muscularis mucosae, with numerous blood vessels and eosinophils, raised the possibility of IFP zImage 3z. No concentric perivascular arrangement of cells was seen. Immunostains for CD34, fascin, and SMA were performed in the case with eosinophilic infiltrate and in 3 additional cases with no particular features. They revealed an increase in fascin-positive cells at the ulcer base but no immunoreactivity for CD34 or SMA in the stromal cells of the fibrous tissue.
The fully developed IFP found in 1 case was sessile, approximately 1 cm in size, based in the submucosa, and associated with overlying ulceration. It showed the typical hypervascular, myxoid, loose stroma with several eosinophils and spindle cells staining with antibodies for CD34 (diffuse positivity), fascin (diffuse positivity), and CD68 (patchy positivity). No perivascular circumferential arrangement of spindle cells was noted.
Reactive enterocytes and crypt distortion were present at the immediate periphery of the ulcers. In every case, focal reactive enteropathy, with or without erosion, was identified, also away from the diaphragms zImage 4z.
Cryptitis and the rare crypt abscesses occurred within the perimeter of the ulcers. The adjacent mucosa appeared normal within a few millimeters with the exception of the presence of crypt shortfall. Lymphoplasmacytic infiltrate in the wall of the intestine was mild in intensity in 8 cases, usually at the periphery of the submucosal soft tissue changes, and moderate in the remaining 2 cases with nodular infiltrates of lymphocytes directly below ulcerations. Transmural inflammation, fissuring ulcerations, or strings of round lymphoid aggregates along the muscularis propria were never identified.
Among the changes commonly associated with chronic injury, UACL was detected near the ulcers of the diaphragms in 6 cases zImage 5z, while the muscularis mucosae showed double tracking in 1 diaphragm in a single case.
A single case showed enteritis cystica profunda (ECP) with few reactive-appearing glands entrapped in the submucosal fibromuscular proliferation.
Eosinophilia limited to the mucosa was identified in 3 cases (average of eosinophils in 10 high-power fields [HPFs] 90/HPF, 129/HPF, and 138/HPF, respectively). The eosinophils were scattered in the lamina propria diffusely with no evidence of cryptitis or abscesses. No peripheral eosinophilia was present. Patchy villous atrophy zImage 6z was seen in 1 case that also had eosinophilia. The villi/crypt ratio reached 
Discussion
NSAIDs are known to cause a high incidence of toxic effects in the small intestine. 2 The deleterious effects of NSAIDs in the small bowel are the results of a myriad of mechanisms (including microvascular injury, cyclooxygenase [COX] 1 and/ or 2 inhibition, products of inflammatory cell infiltration, and zImage 2z A low-power view of the club-shaped tip of a diaphragm shows a nodular lesion in the submucosa with convergence of smooth muscle toward the base of an ulcer. The muscularis mucosae is entangled with the submucosal lesion. Note the relatively scant inflammation and the crypt shortfall on both sides of the ulcer (H&E, ×20).
zImage 3z Crypt shortfall due to loose fibrous tissue at the base of the mucosa with several vessels and eosinophils (H&E, ×100).
expression of inducible nitric oxide synthase). Injuries are the result of local/direct contact and systemic effects. The current hypothesis 24 is that NSAIDs cause initial reduction in villous microcirculation combined with inhibitory action on the cellular oxidative processes of the epithelial cells. These combine to induce increased permeability of the small intestinal mucosa. The injury is aggravated by prolonged exposure to the drug due to enterohepatic recirculation of at least some of the NSAIDs. Increased permeability allows luminal aggressors (indigenous enteral bacteria, their products, and bile) to gain access to the mucosa and cause inflammation with expression of inducible nitric oxide synthase. Reactive oxygen species formation due to infiltration by neutrophils and produced by injured endothelial cells is likely to bring about tissue injury. The NSAID COX-2 inhibitors have substantially reduced the propensity for injury of the small intestine, although they retain a component of side effects, including diaphragm formation. 11 The reason for the reduced toxic zImage 4z Reactive enterocytes, in this case with impending erosion, were found in every case of diaphragm disease (H&E, ×100).
zImage 5z Ulcer-associated cell lineage, also known as pyloric metaplasia, was seen at the base of the mucosa, usually near the ulcerated tips of the diaphragms (H&E, ×200).
zImage 6z Severe, patchy villous atrophy was present in a case showing also eosinophilia of the mucosa (H&E, ×200).
zImage 7z Peculiar perivascular smooth muscle arrangement was seen in the submucosa of a diaphragm in 1 case (H&E, ×100).
IFP. To our knowledge, this is the second reported case of IFP with NSAID-induced enteropathy. 18 IFP is considered a peculiar type of granulation tissue. 37 It is possible that a nonspecific injury (in this case due to NSAIDs) can cause the abnormal stromal reaction of IFP.
The presence of histopathologic evidence of chronic injury in DD is not stated explicitly in the original report of Lang et al 15 or in a recent authoritative review of gastrointestinal diseases. 23 Mucosal architectural distortion, crypt shortfall, and UACL are common at the apex of the diaphragms. Minimal active inflammation can also be present. The resulting picture is that of chronic enteritis with occasional mild activity. The histologic changes appear related primarily to the NSAID-associated damage rather than obstructive enteritis. This conclusion is suggested by the presence of inflammatory changes at the site of obstruction, rather than proximal to it, and by the absence of the ischemic pattern of injury (hemorrhages and larger, irregular ulcers) and of subserosal neutrophilic infiltrates described in obstructive enteritis.
In 1 of our cases, few normal-sized glands with reactive atypia were entrapped in the submucosa, as in ECP. ECP is characterized by glands, often dilated, present in the wall of the small intestine, typically in large polyps of Peutz-Jeghers 38 and in Crohn disease. 39 ECP arises after repeated ulceration and trauma of the mucosa that allows outgrowth in the submucosa. The repeated or persistent injury due to NSAIDs can, therefore, cause gland entrapment and potentially mimic a neoplastic lesion.
NMVH is a controversial entity most commonly reported in the small bowel. It was originally described as "fascicles of smooth muscle derived from the muscularis mucosae, bundles of unmyelinated nerve fibres with scattered ganglion cells, and hemangiomatous vessels, causing stenosis." 22 Cortina et al 17 argued convincingly that DD and NMVH show clinical and histologic similitude on the basis of the study of 2 patients. An identical conclusion is reached in 9 cases from our series. It appears that NMVH and DD are indistinguishable in at least a subset of patients. The presence of a range of sizes for the NMVH-like lesions in our cases and the association with ulceration and/or reactive enteropathy and/or mucosal fibrosis suggests that they are reactive rather than congenital. Sheperd and Jass 40 found NMVH in Crohn disease, additional evidence of the nonspecific reactive nature of the lesion.
Our study has revealed that DD has a distinctive gross appearance associated, however, with a wide array of histologic findings. NSAID-related injury should be considered in the presence of chronic enteritis with scant inflammation, mucosal eosinophilic enteritis, ECP, IFP, villous atrophy, and NMVH. effects in the small bowel is not completely clear, although there is evidence to suggest that COX-1 products have a predominant role in the maintenance of the epithelial barrier integrity. The relationship of the drugs with DD is complicated by our incomplete knowledge of the natural history of these lesions and of the type, duration, interactions, and dosage of NSAIDs taken by patients.
DD is typical of NSAID-related injury of the small intestine 1 but remains an uncommon, although not vanishingly rare, occurrence: In 2% of patients taking NSAIDs and COX-2 inhibitors long-term, DD developed. 25 Women are more commonly affected than are men, and the small intestine is more commonly affected than is the colon. 26 The route of ingestion of NSAIDs does not preclude the formation of diaphragms: DD has been reported in a bypassed bowel segment, suggesting systemic effect of NSAIDs. 27 It is possible that the formation of diaphragms is a nonspecific response to various insults to the intestine. At least 2 cases have been reported in which no NSAID intake could be proven. 20, 28 We identified 10 cases of DD of the small intestine in 4 years. The majority of the specimens were obtained because of retention of the video capsule, suggesting the difficult preoperative diagnosis of this condition. The gross and clinical features were typical and similar to those reported in the literature, [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] 26, 29 with the exception of the diagnosis being reached by video capsule endoscopy in 6 of our cases.
We found that DD was characterized histopathologically by focality, lack of severe inflammation, and the reactive appearance of the changes. We were surprised to find a remarkable array of abnormalities associated with DD (Table  3) . Eosinophilia limited to the mucosal layer with no evidence of eosinophilic cryptitis or eosinophilic abscesses was present in 3 cases. In each of them, the clinical criteria (gastrointestinal symptoms and no evidence of parasitic or extraintestinal disease) for the diagnosis of eosinophilic gastroenteritis were satisfied. 30 Eosinophilia of the small intestine in NSAID enteropathy was noted by Lang et al 15 and is a known manifestation of NSAID colitis. 31 A similar "allergic" drug reaction with small intestine eosinophilia has been reported with other drugs such as enalapril, 32 trimethoprim-sulfonamide, 33 and gemfibrozil. 34 Eosinophils produce mediators that contribute to tissue damage (major basic protein, eosinophil peroxidase, platelet activating factor, leukotrienes, and eosinophil-derived neurotoxin). In 1 of our cases, eosinophilia was associated with villous atrophy. Patchy villous atrophy has been reported previously in patients taking NSAIDs such as mefenamic acid 35 or sulindac. 36 In both reports, the abnormalities disappeared with cessation of the drug and reappeared at rechallenge with the drug. Intraepithelial lymphocytosis was not present.
Interesting was the presence of IFP in 1 case and of occasional changes reminiscent of incompletely developed
